862088-17-3 Usage
Uses
Used in Pharmaceutical Industry:
3,5-DIFLUORO-2-HYDROXYBENZONITRILE is utilized as an intermediate in the synthesis of various pharmaceuticals, contributing to the development of new drugs and therapeutic agents. Its unique structure allows for the creation of diverse medicinal compounds with specific therapeutic properties.
Used in Agrochemical Industry:
In the agrochemical sector, 3,5-DIFLUORO-2-HYDROXYBENZONITRILE serves as a key intermediate in the production of agrochemicals, including pesticides and herbicides. Its incorporation aids in enhancing the effectiveness of these chemicals in agricultural applications.
Used in Organic Chemistry:
3,5-DIFLUORO-2-HYDROXYBENZONITRILE is employed as a building block in organic chemistry reactions, facilitating the synthesis of a wide range of organic compounds for various applications. Its presence in these reactions can influence the properties and reactivity of the resulting products.
Check Digit Verification of cas no
The CAS Registry Mumber 862088-17-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,6,2,0,8 and 8 respectively; the second part has 2 digits, 1 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 862088-17:
(8*8)+(7*6)+(6*2)+(5*0)+(4*8)+(3*8)+(2*1)+(1*7)=183
183 % 10 = 3
So 862088-17-3 is a valid CAS Registry Number.
InChI:InChI=1/C7H3F2NO/c8-5-1-4(3-10)7(11)6(9)2-5/h1-2,11H
862088-17-3Relevant academic research and scientific papers
NOVEL BENZOFURAN DERIVATIVE, MEDICINAL COMPOSITION CONTAINING THE SAME, AND USES OF THESE
-
Page/Page column 21, (2008/06/13)
[From equivalent EP1710233A1] The present invention provides compounds represented by general formula (I): or pharmaceutical acceptable salts thereof, wherein R1 is hydrogen or lower alkyl; R2 is lower alkyl, halo-lower alkyl, cycloalkyl, heterocycloalkyl, aryl, aralkyl, arylalkenyl, aryloxy-lower alkyl, heteroaryl, heteroaryl-lower alkyl, etc; R3, R4, R5 and R6 are each hydrogen, halogen, cyano, lower alkyl, halo-lower alkyl, lower alkoxy, hydroxy, aryl, etc; provided that at least one of R3, R4, R5 and R6 is other than hydrogen. Compound (I) of the present invention shows a potent adenosine A2A receptor antagonistic activity, and are useful for treating or preventing a disease mediated by adenosine A2A receptors such as motor function disorders, depression, anxiety disorders, cognitive function disorders, cerebral ischemia disorders, restless legs syndrome and the like.
